SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,483 | -41.1% | 1,191,202 | +27.6% | 0.00% | – |
| Q2 2023 | $1,213,584 | -32.0% | 933,526 | -7.9% | 0.00% | -100.0% |
| Q1 2023 | $1,784,242 | -44.0% | 1,013,774 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $3,185,191 | -30.9% | 1,014,392 | +7.9% | 0.00% | -50.0% |
| Q3 2022 | $4,607,000 | +26.9% | 940,174 | +7.2% | 0.00% | +100.0% |
| Q2 2022 | $3,631,000 | -29.2% | 876,884 | -0.7% | 0.00% | -50.0% |
| Q1 2022 | $5,130,000 | -19.5% | 882,914 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $6,373,000 | -24.7% | 849,644 | -9.5% | 0.00% | -33.3% |
| Q3 2021 | $8,464,000 | -22.6% | 939,334 | +2.9% | 0.00% | -25.0% |
| Q2 2021 | $10,929,000 | -1.9% | 912,994 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $11,136,000 | -16.1% | 888,704 | +4.5% | 0.00% | -20.0% |
| Q4 2020 | $13,266,000 | +80.9% | 850,088 | +9.5% | 0.01% | +66.7% |
| Q3 2020 | $7,334,000 | +5.4% | 776,053 | -0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,957,000 | +50.1% | 776,407 | +6.7% | 0.00% | 0.0% |
| Q1 2020 | $4,635,000 | -22.8% | 727,490 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $6,004,000 | -4.8% | 717,309 | +2.9% | 0.00% | -25.0% |
| Q3 2019 | $6,309,000 | -13.4% | 697,092 | +3.0% | 0.00% | 0.0% |
| Q2 2019 | $7,287,000 | +29.5% | 676,556 | +14.7% | 0.00% | 0.0% |
| Q1 2019 | $5,628,000 | -13.4% | 589,896 | +4.2% | 0.00% | -20.0% |
| Q4 2018 | $6,497,000 | -35.0% | 565,871 | -4.0% | 0.01% | -28.6% |
| Q3 2018 | $9,989,000 | +24.4% | 589,299 | +4.2% | 0.01% | +16.7% |
| Q2 2018 | $8,032,000 | -14.5% | 565,601 | +14.4% | 0.01% | -14.3% |
| Q1 2018 | $9,395,000 | +32.1% | 494,467 | +14.0% | 0.01% | +16.7% |
| Q4 2017 | $7,113,000 | +24.2% | 433,717 | +13.6% | 0.01% | +20.0% |
| Q3 2017 | $5,729,000 | +143.5% | 381,916 | +42.9% | 0.01% | +150.0% |
| Q2 2017 | $2,353,000 | +70.3% | 267,293 | +0.6% | 0.00% | +100.0% |
| Q1 2017 | $1,382,000 | +79.9% | 265,735 | +5.6% | 0.00% | 0.0% |
| Q4 2016 | $768,000 | -30.6% | 251,713 | +5.3% | 0.00% | 0.0% |
| Q3 2016 | $1,107,000 | -27.8% | 239,085 | -9.7% | 0.00% | -50.0% |
| Q2 2016 | $1,534,000 | -2.4% | 264,847 | +2.0% | 0.00% | 0.0% |
| Q1 2016 | $1,572,000 | -32.2% | 259,681 | +2.2% | 0.00% | -33.3% |
| Q4 2015 | $2,320,000 | +103.7% | 254,000 | +25.8% | 0.00% | +50.0% |
| Q3 2015 | $1,139,000 | -52.5% | 201,829 | -6.6% | 0.00% | -33.3% |
| Q2 2015 | $2,398,000 | -53.3% | 216,149 | -34.0% | 0.00% | -57.1% |
| Q1 2015 | $5,139,000 | +2.0% | 327,709 | -1.0% | 0.01% | -12.5% |
| Q4 2014 | $5,036,000 | +55.1% | 331,034 | +10.0% | 0.01% | +60.0% |
| Q3 2014 | $3,247,000 | +12.2% | 301,034 | +58.9% | 0.01% | 0.0% |
| Q2 2014 | $2,893,000 | -7.1% | 189,428 | +10.0% | 0.01% | -16.7% |
| Q1 2014 | $3,113,000 | +38.2% | 172,132 | +6.2% | 0.01% | +50.0% |
| Q4 2013 | $2,252,000 | +35.2% | 162,120 | +16.7% | 0.00% | +33.3% |
| Q3 2013 | $1,666,000 | +67.8% | 138,920 | +11.6% | 0.00% | +50.0% |
| Q2 2013 | $993,000 | – | 124,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |